404 related articles for article (PubMed ID: 30876970)
41. miR-200a regulates SIRT1 expression and epithelial to mesenchymal transition (EMT)-like transformation in mammary epithelial cells.
Eades G; Yao Y; Yang M; Zhang Y; Chumsri S; Zhou Q
J Biol Chem; 2011 Jul; 286(29):25992-6002. PubMed ID: 21596753
[TBL] [Abstract][Full Text] [Related]
42. Suppression of epithelial-mesenchymal transition and SIRT1/AKT signaling pathway in breast cancer by montelukast.
El-Ashmawy NE; Khedr EG; Khedr NF; El-Adawy SA
Int Immunopharmacol; 2023 Jun; 119():110148. PubMed ID: 37044036
[TBL] [Abstract][Full Text] [Related]
43. Cyanidin-3-O-Glucoside Ameliorates Lipopolysaccharide-Induced Injury Both In Vivo and In Vitro Suppression of NF-κB and MAPK Pathways.
Ma MM; Li Y; Liu XY; Zhu WW; Ren X; Kong GQ; Huang X; Wang LP; Luo LQ; Wang XZ
Inflammation; 2015 Aug; 38(4):1669-82. PubMed ID: 25752620
[TBL] [Abstract][Full Text] [Related]
44. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
45. 2-Methoxy-5((3,4,5-trimethosyphenyl)seleninyl) phenol (SQ) inhibits cancer cell metastasis behavior of TNBC via suppressing EMT and VEGF.
Zheng D; Wu Z; Han J; Guan Q; Li Z; Zuo D; Zhang W; Wu Y
Chem Biol Interact; 2020 Sep; 329():109202. PubMed ID: 32717189
[TBL] [Abstract][Full Text] [Related]
46. Garcinol regulates EMT and Wnt signaling pathways in vitro and in vivo, leading to anticancer activity against breast cancer cells.
Ahmad A; Sarkar SH; Bitar B; Ali S; Aboukameel A; Sethi S; Li Y; Bao B; Kong D; Banerjee S; Padhye SB; Sarkar FH
Mol Cancer Ther; 2012 Oct; 11(10):2193-201. PubMed ID: 22821148
[TBL] [Abstract][Full Text] [Related]
47. Cyanidin-3-O-glucoside attenuates endothelial cell dysfunction by modulating miR-204-5p/SIRT1-mediated inflammation and apoptosis.
Wang Z; Zhang M; Wang Z; Guo Z; Wang Z; Chen Q
Biofactors; 2020 Sep; 46(5):803-812. PubMed ID: 32593198
[TBL] [Abstract][Full Text] [Related]
48. p38 maintains E-cadherin expression by modulating TAK1-NF-kappa B during epithelial-to-mesenchymal transition.
Strippoli R; Benedicto I; Foronda M; Perez-Lozano ML; Sánchez-Perales S; López-Cabrera M; Del Pozo MÁ
J Cell Sci; 2010 Dec; 123(Pt 24):4321-31. PubMed ID: 21098640
[TBL] [Abstract][Full Text] [Related]
49. Luteolin suppresses epithelial-mesenchymal transition and migration of triple-negative breast cancer cells by inhibiting YAP/TAZ activity.
Cao D; Zhu GY; Lu Y; Yang A; Chen D; Huang HJ; Peng SX; Chen LW; Li YW
Biomed Pharmacother; 2020 Sep; 129():110462. PubMed ID: 32768952
[TBL] [Abstract][Full Text] [Related]
50. Epithelial-mesenchymal transition in breast epithelial cells treated with cadmium and the role of Snail.
Wei Z; Shan Z; Shaikh ZA
Toxicol Appl Pharmacol; 2018 Apr; 344():46-55. PubMed ID: 29501589
[TBL] [Abstract][Full Text] [Related]
51. Effect of SIRT1 Gene on Epithelial-Mesenchymal Transition of Human Prostate Cancer PC-3 Cells.
Cui Y; Li J; Zheng F; Ouyang Y; Chen X; Zhang L; Chen Y; Wang L; Mu S; Zhang H
Med Sci Monit; 2016 Feb; 22():380-6. PubMed ID: 26847404
[TBL] [Abstract][Full Text] [Related]
52. The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line.
Satram-Maharaj T; Nyarko JN; Kuski K; Fehr K; Pennington PR; Truitt L; Freywald A; Lukong KE; Anderson DH; Mousseau DD
Cell Signal; 2014 Dec; 26(12):2621-32. PubMed ID: 25152370
[TBL] [Abstract][Full Text] [Related]
53. MiR-92b inhibited cells EMT by targeting Gabra3 and predicted prognosis of triple negative breast cancer patients.
Li YY; Zheng XH; Deng AP; Wang Y; Liu J; Zhou Q; Cheng GY; Jiang Q
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10433-10442. PubMed ID: 31841197
[TBL] [Abstract][Full Text] [Related]
54. Osthole inhibited TGF β-induced epithelial-mesenchymal transition (EMT) by suppressing NF-κB mediated Snail activation in lung cancer A549 cells.
Feng H; Lu JJ; Wang Y; Pei L; Chen X
Cell Adh Migr; 2017 Sep; 11(5-6):464-475. PubMed ID: 28146373
[TBL] [Abstract][Full Text] [Related]
55. miR-124 regulates EMT based on ZEB2 target to inhibit invasion and metastasis in triple-negative breast cancer.
Ji H; Sang M; Liu F; Ai N; Geng C
Pathol Res Pract; 2019 Apr; 215(4):697-704. PubMed ID: 30611621
[TBL] [Abstract][Full Text] [Related]
56. RBM38 is involved in TGF-β-induced epithelial-to-mesenchymal transition by stabilising zonula occludens-1 mRNA in breast cancer.
Wu J; Zhou XJ; Sun X; Xia TS; Li XX; Shi L; Zhu L; Zhou WB; Wei JF; Ding Q
Br J Cancer; 2017 Aug; 117(5):675-684. PubMed ID: 28683467
[TBL] [Abstract][Full Text] [Related]
57. Quercetin regulates β-catenin signaling and reduces the migration of triple negative breast cancer.
Srinivasan A; Thangavel C; Liu Y; Shoyele S; Den RB; Selvakumar P; Lakshmikuttyamma A
Mol Carcinog; 2016 May; 55(5):743-56. PubMed ID: 25968914
[TBL] [Abstract][Full Text] [Related]
58. Resveratrol enhances the sensitivity of FL118 in triple-negative breast cancer cell lines via suppressing epithelial to mesenchymal transition.
Yar Saglam AS; Kayhan H; Alp E; Onen HI
Mol Biol Rep; 2021 Jan; 48(1):475-489. PubMed ID: 33389483
[TBL] [Abstract][Full Text] [Related]
59. ZEB2 stably represses RAB25 expression through epigenetic regulation by SIRT1 and DNMTs during epithelial-to-mesenchymal transition.
Skrypek N; Bruneel K; Vandewalle C; De Smedt E; Soen B; Loret N; Taminau J; Goossens S; Vandamme N; Berx G
Epigenetics Chromatin; 2018 Nov; 11(1):70. PubMed ID: 30445998
[TBL] [Abstract][Full Text] [Related]
60. Annurca apple polyphenol extract promotes mesenchymal-to-epithelial transition and inhibits migration in triple-negative breast cancer cells through ROS/JNK signaling.
Vuoso DC; D'Angelo S; Ferraro R; Caserta S; Guido S; Cammarota M; Porcelli M; Cacciapuoti G
Sci Rep; 2020 Sep; 10(1):15921. PubMed ID: 32985606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]